Reading XRN? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track XRN free→Reading XRN? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track XRN free→QuarterlyIQ Insights · XRN
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
below. The Company will operate the Landing as a senior housing operating property (“ SHOP ”) asset and, on June 1, 2026, entered into a management agreement with an affiliate of Greystone Communities (“ Greystone ”), a third-party operator, pursuant to which Greystone will manage the day-to-day operations of the Landing. The Riviera Alexandria On June 1, 2026, the Company, through one or more subsidiaries, closed on the acquisition of The Riviera Alexandria (the “ Riviera ”), a senior housin…
Completion of Acquisition or Disposition of Assets The Landing Alexandria On June 1, 2026, the Company, through one or more subsidiaries, closed on the acquisition of The Landing Alexandria (the “ Landing ”), a senior housing community located in Alexandria, Virginia for a purchase price of $130 million. The Company previously reported on a Current Report on Form 8-K filed with the United States Securities and Exchange Commission (the “ Commission ”) on May 6, 2026 (the “ May 6, 2026 8-K ”) t…
Unregistered Sales of Equity Securities On May 29, 2026 and June 2, 2026, the Company completed closings of its previously announced private placement (the “ Series C Private Placement ”), pursuant to which the Company issued an aggregate of 1,000,000 shares of Series C Preferred Stock for $100.00 per share for gross proceeds of approximately $100,000,000 to Maewyn XRN LP, Petrus Special Opportunities Fund, L.P., certain entities advised by Canyon Capital Advisors LLC and certain entities adv…
Material Modification to Rights of Security Holders. On May 28, 2026, the Company filed Articles Supplementary with the Maryland State Department of Assessments and Taxation to designate 1,000,000 shares of the Company’s authorized preferred stock as shares of Series C Convertible Preferred Stock (the “ Articles Supplementary ”), with the powers, preferences and privileges as set forth in the Articles Supplementary. The Articles Supplementary were effective upon filing. Upon issuance of the S…
Entry into a Material Definitive Agreement Seventh Amendment to the Agreement of Limited Partnership of Chiron Real Estate LP On May 28, 2026, Chiron Real Estate Inc. (the “ Company ”), as the sole member of the general partner of Chiron Real Estate LP (the “ Operating Partnership ”), entered into an amendment to the agreement of limited partnership of the Operating Partnership (the “ OP Amendment ”). The OP Amendment creates a new class of partnership units designated as Series C Convertible…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment of Mr. Charles Fitzgerald to the Board of Directors (d) On May 20, 2026, the Board of Directors (the “ Board ”) of Chiron Real Estate Inc. (the “ Company ”) approved an increase in the number of directors constituting the Board from six to seven directors and appointed Charles Fitzgerald to serve as a director of the Company, effective…
of the Company’s Current Report on Form 8-K filed with the SEC on May 8, 2026, which description is incorporated herein by reference, including Mr. Fitzgerald’s indirect interest in the transaction through his role as Managing Partner of Maewyn Capital Partners LLC, the investment manager to Maewyn XRN LP, a party to such transaction, there are no arrangements or understandings between Mr. Fitzgerald and any other persons or entities pursuant to which Mr. Fitzgerald was appointed as director…
Entry into a Material Definitive Agreement Investment Agreement On May 6, 2026, Chiron Real Estate Inc. (the “Company”) entered into an Investment Agreement (the “Investment Agreement”) with Maewyn XRN LP (the “Maewyn Purchaser”) and each other purchaser that may become a party to this Investment Agreement from time to time (collectively, the “Purchasers”). Pursuant to the Investment Agreement, the Company agreed to issue and sell to the Purchasers a total of 1,000,000 shares of a new series…
As described in Item 1.01, under the terms of the Investment Agreement, the Company has agreed to issue up to 1,000,000 shares of Series C Preferred Stock to the Purchasers. The offer and sale of the Series C Preferred Stock are being made, and the issuance of the Series C Preferred Stock will be made, in reliance upon the exemption from registration provided by Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D promulgated thereunder. The Company relied on these exemptions fr…
Results of Operations and Financial Condition On May 6, 2026, the Company announced its financial position as of March 31, 2026 and operating results for the three months ended March 31, 2026 and other related information (the “Earnings Release”). The Company also posted its First Quarter 2026 Earnings Supplemental (the “Supplemental”) to the Company’s website at www.chironre.com. The Earnings Release and Supplemental are furnished as Exhibit 99.1 and Exhibit 99.2, respectively, and are incor…
Entry into a Material Definitive Agreement The Landing Alexandria On May 1, 2026, Chiron Real Estate Inc. (the “Company”), through one or more subsidiaries, entered into a purchase and sale agreement (the “Landing Purchase Agreement”) with affiliates of Silverstone Senior Living (“Silverstone”) to acquire The Landing Alexandria (the “Landing”), a senior housing community located in Alexandria, Virginia, for a purchase price of $130.0 million, subject to customary prorations and adjustments. I…
Entry into a Material Definitive Agreement. Sixth Amendment to Agreement of Limited Partnership of Chiron Real Estate LP In connection with the Preferred ATM Offering (as defined below) by Chiron Real Estate Inc. (the “Company”) of the Company’s 8.00% Series B Cumulative Redeemable Preferred Stock (the “Series B Preferred Stock”), the Agreement of Limited Partnership of Chiron Real Estate LP (the “Operating Partnership”) was amended (the “Amendment”) to provide for the issuance of up to an ad…
Other Events. Common At-the-Market Offering Program On March 12, 2026, the Company and the Operating Partnership entered into an Amended and Restated Sales Agreement (the “Common Sales Agreement”) with (i) BMO Capital Markets Corp., A.G.P./Alliance Global Partners, B. Riley Securities, Inc., Robert W. Baird & Co. Incorporated, Berenberg Capital Markets LLC, Colliers Securities LLC, Citizens JMP Securities, LLC, Huntington Securities, Inc., J.P. Morgan Securities LLC, Raymond James & Associate…
Entry into a Material Definitive Agreement. On March 2, 2026, Chiron Real Estate LP (the “Operating Partnership”), as issuer, and Chiron Real Estate Inc., as a guarantor, entered into a Master Note and Guaranty Agreement (the “Agreement”) with NYL Investors LLC (“New York Life”) and certain affiliates of New York Life (collectively, the “Purchasers”). The Agreement establishes an uncommitted senior note facility pursuant to which the Operating Partnership may, from time to time, issue senior…
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information disclosed above in
Results of Operations and Financial Condition. On February 25, 2026, Chiron Real Estate Inc. (the “Company”) announced its financial position as of December 31, 2025 and operating results for the three months and year ended December 31, 2025 and other related information (the “Earnings Release”). The Company also posted its Fourth Quarter 2025 Earnings Supplemental (the “Supplemental”) to the Company’s website at www.chironre.com. The Earnings Release and Supplemental are furnished as Exhibit…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 23, 2026, Mr. Henry Cole notified the Board of Directors (the “Board”) of Global Medical REIT Inc. (the “Company”) that he intends to step down as a director of the Company, effective as of the Company’s 2026 Annual Meeting of Stockholders (the “Annual Meeting”). Accordingly, Mr. Cole will not be nominated by the Board for election as a…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On December 3, 2025, Mr. Ronald Marston notified the Board of Directors (the “Board”) of Global Medical REIT Inc. (the “Company”) that he intends to retire as a director of the Company, effective as of the Company’s 2026 Annual Meeting of Stockholders (the “Annual Meeting”). Accordingly, Mr. Marston will not be nominated by the Board for election a…
Material Modification to Rights of Security Holders. On November 18, 2025, the Company filed Articles Supplementary with the Maryland State Department of Assessments and Taxation to designate 2,300,000 shares of the Company’s authorized preferred stock as shares of 8.00% Series B Cumulative Redeemable Preferred Stock, par value $0.001 per share, with a liquidation preference of $25.00 per share (“Series B Preferred Stock”), with the powers, preferences and privileges as set forth in the Artic…
Entry into a Material Definitive Agreement. Underwriting Agreement On November 13, 2025, Global Medical REIT Inc. (the “Company”) and Global Medical REIT L.P., the Company’s operating partnership (the “Operating Partnership”), entered into an Underwriting Agreement (the “Underwriting Agreement”) with Raymond James & Associates, Inc., BMO Capital Markets Corp., Stifel, Nicolaus & Company, Incorporated and Robert W. Baird & Co. Incorporated, as the representatives of the underwriters named in S…
Other Events. Third Quarter 2025 Results On November 4, 2025, Global Medical REIT Inc. (the “ Company ”) announced net loss attributable to common stockholders for the quarter ended September 30, 2025 of approximately $6.0 million, or approximately $0.45 per diluted share, as compared to net income of approximately $1.8 million, or approximately $0.14 per diluted share, in the comparable prior year period. The Company also reported net loss attributable to common stockholders for the nine mon…
Results of Operations and Financial Condition. On November 4, 2025, Global Medical REIT Inc. (the “ Company ”) announced its financial position as of September 30, 2025 and operating results for the three and nine months ended September 30, 2025 and other related information (the “ Earnings Release ”). The Company also posted its Third Quarter 2025 Earnings Supplemental (the “ Supplemental ”) to the Company’s website at www.globalmedicalreit.com. The Earnings Release and Supplemental are furn…
Entry into a Material Definitive Agreement. On October 8, 2025, Global Medical REIT Inc. (the “Company”), Global Medical REIT L.P. (the “Operating Partnership”), as borrower, and certain subsidiaries of the Operating Partnership (such subsidiaries, the “Subsidiary Guarantors”) entered into a third amended and restated credit agreement (the “Third A&R Credit Facility”) with JPMorgan Chase Bank, N.A., as administrative agent, which contains the following material amendments to the Company’s pre…
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information disclosed above in
Material Modification to Rights of Security Holders. On September 18, 2025, in connection with the previously announced one-for-five reverse stock split (the “Reverse Stock Split”) of shares of common stock, par value $0.001 per share (the “Common Stock”), of Global Medical REIT Inc. (the “Company”), the Company filed Articles of Amendment to its charter (the “Amendment”) with the Maryland State Department of Assessments and Taxation. The Amendment, effective as of 5:00 p.m. Eastern Time on S…
Importance-ranked changes since the prior daily snapshot.
Valuation fell by 56.0 points (from 70.0 to 14.0).
Composite insight fell by 17.6 points (from 2.9 to -14.7).
Signal changed from 'mixed' to 'cautious'.
Valuation label changed from 'inexpensive' to 'expensive'.
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.